ratiopharm Canada is pleased to announce that it has won a five-year legal battle against Pfizer to allow the marketing of Amlodipine Besylate (Norvasc(R)) by Canadian generic manufacturers. ratiopharm was the first company to challenge the Amlodipine Besylate patent in 2004 and the only company to successfully see the case through to the Federal Court decision announced on July 8, 2009.
The details can be read here.
No comments:
Post a Comment